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Summary
Background National estimates for the numbers of babies born small for gestational age and the comorbidity with 
preterm birth are unavailable. We aimed to estimate the prevalence of term and preterm babies born small for 
gestational age (term-SGA and preterm-SGA), and the relation to low birthweight (<2500 g), in 138 countries of low 
and middle income in 2010.
Methods Small for gestational age was deﬁ ned as lower than the 10th centile for fetal growth from the 1991 US national 
reference population. Data from 22 birth cohort studies (14 low-income and middle-income countries) and from the 
WHO Global Survey on Maternal and Perinatal Health (23 countries) were used to model the prevalence of term-SGA 
births. Prevalence of preterm-SGA infants was calculated from meta-analyses. 
Findings In 2010, an estimated 32·4 million infants were born small for gestational age in low-income and middle-
income countries (27% of livebirths), of whom 10·6 million infants were born at term and low birthweight. The 
prevalence of term-SGA babies ranged from 5·3% of livebirths in east Asia to 41·5% in south Asia, and the prevalence 
of preterm-SGA infants ranged from 1·2% in north Africa to 3·0% in southeast Asia. Of 18 million low-birthweight 
babies, 59% were term-SGA and 41% were preterm. Two-thirds of small-for-gestational-age infants were born in Asia 
(17·4 million in south Asia). Preterm-SGA babies totalled 2·8 million births in low-income and middle-income 
countries. Most small-for-gestational-age infants were born in India, Pakistan, Nigeria, and Bangladesh.
Interpretation The burden of small-for-gestational-age births is very high in countries of low and middle income and 
is concentrated in south Asia. Implementation of eﬀ ective interventions for babies born too small or too soon is an 
urgent priority to increase survival and reduce disability, stunting, and non-communicable diseases.
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Introduction
An estimated 20 million infants are born globally with 
low birthweight (<2500 g) every year.1 Low birthweight 
is an important population indicator for tracking 
neonatal health and includes babies born preterm 
(<37 completed weeks of gestation) and infants with 
intrauterine growth restriction. These components of 
low birthweight have diﬀ erent causes and risks of 
mortality, morbidity, impaired growth, and non-
communicable diseases. Hence, for us to guide 
interventions to address both prevention and care, we 
must delineate low birthweight according to preterm 
birth, intrauterine growth restriction, and their overlap.
National estimates of preterm birth for 184 countries 
have been published for the year 2010,2 showing a total of 
14·9 million preterm births. In the Global Burden of 
Disease Study,3 77 million (3·1%) disability-adjusted life-
years were attributed to preterm birth, similar to the 
burden of HIV or malaria. In 1998, de Onis and 
colleagues4 reported estimates of intrauterine growth 
restriction, using babies born full term and with low 
birthweight as a proxy measure. They estimated that 
13·7 million babies were born at term and with low 
birthweight every year, but they did not provide national 
estimates.4 Furthermore, no estimates are available for 
the co-occurrence of intrauterine growth restriction and 
preterm birth, or the relation between intrauterine 
growth restriction and the widely used metric of low 
birthweight.
The classiﬁ cation of small for gestational age was 
deﬁ ned by a 1995 WHO expert committee as infants 
below the 10th centile of a birthweight-for-gestational-age, 
gender-speciﬁ c reference population.5,6 A major challenge 
is selection of an appropriate global reference. Small for 
gestational age is a commonly accepted proxy measure of 
intrauterine growth restriction.5 However, small for 
gestational age includes babies who are constitutionally 
small and in the lower tail of the growth curve, in addition 
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to infants who were growth-restricted in utero because of 
maternal and environmental factors, such as chronic 
under nutrition, multiple pregnancy, placental 
insuﬃ  ciency, pregnancy complications (eg, pre-
eclampsia), infections, and other toxic exposures.7 In 
settings with high rates of small-for-gestational-age 
births, growth restriction accounts for a high proportion 
of these,4 justifying its use as a proxy for intrauterine 
growth restriction. 
Our aim is to estimate the national prevalence and 
numbers of neonates born small for gestational age at 
full term (≥37 weeks; term-SGA), and the co-occurrence 
of small for gestational age with preterm birth 
(preterm-SGA), in 138 countries of low and middle 
income. We focus on this group of countries in view of 
their high burden of disease and the urgent need for data 
to direct, monitor, and assess public health planning in 
these regions.
Methods
Deﬁ nitions
We deﬁ ned small for gestational age as a birthweight 
lower than the 10th centile for a speciﬁ c completed 
gestational age by gender, using the Alexander reference 
population8 (US National Center for Health Statistics, 
1991; n=3 134 879 livebirths). We deﬁ ned term-SGA as a 
baby born small for gestational age at 37 or more 
completed weeks of gestation, and we classiﬁ ed 
preterm-SGA as infants born small for gestational age at 
fewer than 37 weeks of gestation. We deﬁ ned low 
birthweight as a baby born weighing less than 2500 g. 
Finally, we deﬁ ned appropriate for gestational age as a 
birthweight on or higher than the 10th centile for 
gestational age, using the Alexander reference. 
Data sources
We obtained data from three sources: (1) systematic 
literature reviews to identify birth cohorts with 
information on birthweight and gestational age; 
(2) research networks of birth cohorts; and (3) the WHO 
Global Survey on Maternal and Perinatal Health.9 We 
considered datasets for inclusion if they contained 
information on: birthweight; gestational age measured 
by last menstrual period, ultrasound, or clinical 
assessment; and vital status (required for analyses 
described elsewhere).10 Our exclusion criteria were: 
datasets missing more than 25% of data for birthweight 
or gestational age; inaccurate gestational age ascertained 
by study investigators (ie, poorly linked gestational age–
birthweight data, or gestational age reported in months); 
and gestational age established by symphysis fundal 
height. We only included weight in analyses if the 
measurement was made within 72 h of birth. 
We initially searched Medline and WHO regional 
databases (LILACS, AIM, and EMRO) in September, 
2009, to identify potential birth cohorts with data required 
for a larger scope of secondary analyses related to preterm 
birth and small-for-gestational-age-related mortality 
(appendix p 1).10 We identiﬁ ed additional datasets within 
maternal-neonatal research networks (ongoing maternal-
newborn health studies, demographic surveillance sites, 
and WHO UNIMAPP11 studies). We contacted 
investigators to ascertain whether their studies met our 
inclusion criteria and, if so, we asked them to join the 
Child Health Epidemiology Reference Group (CHERG) 
SGA-Preterm Birth working group and contribute data 
for secondary analyses (appendix pp 2–4).10 We did 
another literature review in February, 2012, to identify 
published studies reporting the prevalence of both small-
for-gestational-age births, using the Alexander reference,8 
and low birthweight to use for statistical modelling, since 
low birthweight was the primary independent modelling 
predictor. We implemented two strategies: (1) a Medline 
search using terms (“small-for-gestational-age” OR 
“intrauterine growth restriction”) AND “low birthweight” 
AND (“incidence” OR “prevalence”) AND “developing 
country”; and (2) a Scopus search identifying all 
published articles that have cited small for gestational 
age using the Alexander reference.8 Further details on 
our search strategy are in the appendix (p 5).
We also analysed data from the WHO Global Survey on 
Maternal and Perinatal Health (appendix p 6),9 which 
gathered data between 2004 and 2008 from 373 facilities 
in 24 countries and included 290 610 births. We excluded 
data from Japan (n=3318) because it is a high-income 
country. Therefore, a total of 23 countries contributed to 
the analysis. Details of survey methods are reported 
elsewhere.9 The WHO Global Survey selected countries 
randomly from every WHO subregion and then picked 
facilities at random from the capital city and two other 
randomly selected provinces. For this facility-based 
survey, trained data collectors abstracted relevant data 
from medical records into standardised forms from all 
births in the facility over a speciﬁ c period. Several 
facilities had data with improbable values or 
unrepresentative data. To exclude these poor data-quality 
facilities, we omitted those with fewer than 500 births 
(small sample size), preterm birth rates greater than 40% 
or less than 3% (outside biological plausibility range), or 
rates of low birthweight less than 1% (implausible). We 
aggregated data at the country level. 
Datasets analysed by the original study investigators 
were approved by existing site institutional review boards. 
For datasets shared with the CHERG working group, 
personal identiﬁ ers were not included and, therefore, 
were deemed exempt by the Johns Hopkins Bloomberg 
School of Public Health institutional review board.
Procedures
In the ﬁ rst step of the estimation process, we developed a 
model to estimate the national prevalence of term-SGA, 
based on the included input data. We then estimated the 
prevalence of preterm-SGA, using meta-analytical 
methods, and we applied these proportions to recent 
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national preterm birth estimates developed by members 
of our working group.2 
We used Stata 11.0 for all analyses. We did random-
eﬀ ects regression with logit(term-SGA prevalence) as the 
dependent variable and study region as the clustered unit 
of analysis (appendix p 7). Variables tested included: 
biological factors (prevalence of low birthweight, neonatal 
mortality rate); health-care access (proportion of 
deliveries in a facility, proportion of births by caesarean 
section, proportion of mothers with more than four 
antenatal care visits); and demographic factors 
(proportion of cohort in highest risk categories of 
maternal age, parity, and maternal education). We created 
categorical dummy variables for: degree of selection bias 
(population-based or community-level recruitment, 
facility-based or antenatal care recruitment with some or 
minimum selection bias, tertiary care or referral facility); 
study decade; and method of assessment of gestational 
age (last menstrual period, ultrasound, clinical). To 
examine candidate models, we included the natural log 
of low-birthweight prevalence as the main predictor, 
added individual predictors, and assessed for signiﬁ cance 
(p<0·05), improvement in adjusted R², and Akaike 
information criterion. To select the ﬁ nal model, we did 
cross-validation12 to compare prediction accuracy between 
potential models (appendix p 8). 
We undertook sensitivity analyses using two datasets. 
In the ﬁ rst (modelling dataset A, n=45), we included all 
birth cohort data. In the second restricted dataset 
(modelling dataset B, n=20), we included only population-
representative studies, excluding facility-based studies 
that might have selection bias (WHO studies,9 Pakistan 
Aga Khan University [ZAB], Uganda 200513). Both 
datasets A and B resulted in similar estimates of variables 
and model ﬁ t; thus, we present results of the larger 
dataset A, which enabled cross-validation. We also did 
multiple imputation14 to incorporate infants with missing 
birthweight back into the individual cohort studies 
(appendix p 9).
For every cohort in dataset A, we calculated the 
prevalence of small-for-gestational-age babies within two 
categories of preterm births: moderate-to-late preterm 
(between 32 weeks and <37 weeks of gestation) and early 
preterm (<32 weeks of gestation). We used random-
eﬀ ects meta-analyses to estimate the pooled regional and 
overall prevalence of infants born small for gestational 
age between 32 weeks and less than 37 weeks of gestation 
and those born at less than 32 weeks of gestation. We did 
sensitivity analyses to look at the eﬀ ect of region, facility-
based versus community-based recruitment, and study 
quality. We judged studies of a high quality to be those 
with population-based recruitment, adequate data 
capture (deﬁ ned as missing <15% of birthweight data 
and <30% of birthweight data among neonatal deaths, 
and the proportion of infants born at <32 weeks 
comprising at least 5% of preterm births), and biological 
plausibility (prevalence of small for gestational age >1%).
We used the prediction model to estimate term-SGA 
prevalence in countries of low and middle income 
(UN Millennium Development Goal [MDG] classi-
ﬁ cation) for the year 2010. We took national neonatal 
mortality rates from the UN Interagency Group for Child 
Mortality Estimation15 and low-birthweight rates from 
several sources (appendix p 10). To obtain the number of 
small-for-gestational-age liveborn infants, we multiplied 
the prevalence of term and preterm small for gestational 
age by the estimated number of livebirths for 2010.16 We 
used a bootstrap approach to estimate ranges of 
uncertainty (appendix p 11). 
In every dataset, we calculated the proportion of 
term-SGA infants who were low birthweight and did 
meta-analyses, using random eﬀ ects to pool the estimate 
at the major regional level. We multiplied this value by 
term-SGA estimates for every country and summarised 
them regionally.
Role of the funding source
The sponsor of the study had no role in study design, 
data collection, data analysis, data interpretation, or 
writing of the report. The corresponding author had full 
access to all the data in the study and had ﬁ nal 
responsibility for the decision to submit for publication.
Results
The appendix shows data inputs for the estimation 
process (p 12), study characteristics of the 22 CHERG 
cohorts included in our study13,17–36 (pp 2–4), and survey 
characteristics for the WHO datasets9 (p 6). From the 
literature review, we identiﬁ ed six studies reporting 
prevalence of babies born small for gestational age and 
the proportion of low-birthweight infants (appendix 
p 5); however, none of these studies could be used 
because term-SGA or preterm-SGA rates were not 
reported. Table 1 shows the ﬁ nal model for term-SGA. 
Logit(term-SGA prevalence) increased with rising rates 
of low birthweight and neonatal mortality (ﬁ gure 1). 
Regional random eﬀ ects were applied to account for 
regional variations of the relations. With low 
birthweight and neonatal mortality included in the 
Description Coeﬃ  cient (95% CI) p 
ln(LBW prevalence) Natural log of LBW prevalence 0·997 
(0·732 to 1·262)
<0·0001 
Neonatal mortality 
rate 
Neonatal mortality rate 0·012 
(0·003 to 0·022)
0·010
Population selection 
dummy variable 
Dummy variable to indicate facility recruitment 
in setting with high institutional delivery 
0·246 
(–0·114 to 0·606)
0·181 
Population selection 
dummy variable
Dummy variable to indicate facility-based 
recruitment and selection bias 
0·108 
(–0·203 to 0·419)
0·496
_cons .. –4·160 
(–4·968 to –3·352)
<0·0001
Adjusted R²=0·8237. LBW=low birthweight. SGA=small for gestational age.
Table 1: Final statistical model for logit(term-SGA prevalence) 
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Figure 1: Scatterplots showing 
the relation of term-SGA to LBW 
and neonatal mortality rate
(A) logit(term-SGA prevalence) 
versus ln(LBW prevalence). 
(B) logit(term-SGA prevalence) 
versus neonatal mortality rate.  
SGA=small for gestational age. 
LBW=low birthweight.
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model, socioeconomic covariates were not signiﬁ cant 
and, thus, not retained in the ﬁ nal model. Data source 
covariates were retained to control for selection bias 
and data quality. Regression diagnostic plots are shown 
in the appendix (p 13); the overall model ﬁ t was good 
(adjusted R² 0·8237).
Meta-analyses for the prevalence of babies born small 
for gestational age are presented in the appendix for 
moderate-to-late preterm infants (32 weeks to <37 weeks 
of gestation; pp 14–16) and for early preterm infants 
(<32 weeks of gestation; pp 17–18). Overall, in moderate-
to-late preterm infants, 22·0% were small for gestational 
age (Asia 24·4%; Africa 17·0%; Latin America and the 
Caribbean 22·7%; appendix p 14). Prevalence of babies 
born small for gestational age in the moderate-to-late 
preterm group was similar in community-based and 
facility-based studies in Asia (appendix p 15), and when 
restricted to high-quality studies (p 16). For early preterm 
infants (born at <32 weeks of gestation), the potential for 
selection bias was greater, in view of early mortality 
before weighing in community-based cohorts and 
incomplete data capture. In Asia, prevalence of 
preterm-SGA was highest in facility-based studies (9·0% 
in nine facility studies vs 2·1% in six community studies; 
appendix p 17). With high-quality datasets, the overall 
prevalence of babies born small for gestational age before 
32 weeks of gestation was 11·0% (appendix p 18). In 
sensitivity analyses, we noted no eﬀ ect of imputation of 
missing birthweight data on the prevalence of 
preterm-SGA in four Asian and two African datasets 
(appendix p 9). 
Figure 2 shows the estimated national prevalences of 
small-for-gestational-age births in low-income and 
middle-income countries for the year 2010 (a complete 
list of national estimates is available in the appendix 
pp 19–23). Table 2 presents the numbers and prevalence 
of term-SGA, preterm-SGA, and all small-for-gestational-
age births, by UN-MDG region. Prevalence of term-SGA 
ranged from 5·3% in east Asia to as high as 41·5% in 
south Asia, and preterm-SGA ranged from 1·2% in north 
Africa to 3·0% in southeast Asia. For all small-for-
gestational-age births, the highest prevalence was 
recorded in south Asia (44·5%), followed by sub-Saharan 
Africa (25·5%) and southeast Asia (24·3%). The greatest 
numbers of term-SGA infants were born in south Asia 
(16·2 million) and sub-Saharan Africa (7·5 million). 
Although their absolute numbers are lower, preterm-SGA 
infants carry a higher risk of mortality in the newborn 
and infant periods than do term-SGA infants;10 numbers 
of preterm-SGA babies totalled 1·2 million in south Asia 
and 0·6 million in sub-Saharan Africa. The vast majority 
of small-for-gestational-age infants (87%, 28·2 million) 
were born in south Asia, southeast Asia, and sub-Saharan 
Africa.
Figure 3 presents prevalence data for term-SGA, 
preterm-SGA, and preterm appropriate-for-gestational-
age births, compared with the prevalence of babies born 
with low birthweight. Table 2 also shows the estimated 
numbers of term-SGA infants who weighed less than 
2500 g at birth (term-SGA and with low birthweight), by 
UN-MDG region for 2010. In all regions, the majority 
(>50%) of term-SGA infants weighed 2500 g or heavier, 
with high proportions of babies not low birthweight but 
small for gestational age in Africa (74%) and Latin America 
and the Caribbean (71%). The highest regional proportion 
of low-birthweight babies was recorded in south Asia 
(26%), and the prevalence of term-SGA infants was also 
very high in this region (42%). Term-SGA accounted for 
65% of low-birthweight babies in south Asia and 
preterm birth accounted for 35%. In sub-Saharan Africa, 
although preterm birth rates were similar to those in 
south Asia, the rate of low-birthweight babies was lower 
(14%) and preterm birth made a relatively larger 
contribution to the low-birthweight metric (57% preterm 
birth vs 43% term-SGA). Similarly in Latin America and 
the Caribbean, preterm birth comprised a larger 
proportion of the low-birthweight metric (60% preterm 
birth vs 40% term-SGA). In east Asia, the proportion of 
low-birthweight infants was very low (2·6%) and consisted 
mainly of preterm-SGA infants. In regions with lower 
rates of low-birthweight babies, such as north Africa or 
east Asia, preterm birth seems the more inﬂ uential 
contributor to the low-birthweight metric.
Overall, in countries of low and middle income in 2010, 
an estimated 43·3 million infants (36% of livebirths) 
were born either preterm or small for gestational age, or 
both (ﬁ gure 4). Of 18 million low-birthweight infants, 
59% were term-SGA whereas 41% were preterm (16% 
preterm-SGA, 25% preterm and appropriate size for 
gestational age).
Table 3 shows the ten countries with the largest 
numbers of small-for-gestational-age infants born in 
2010. An estimated 12·8 million babies were born small 
for gestational age in India alone (95% CI 11·5–14·3 
million), with a prevalence of 47%. Pakistan, Nigeria, 
Bangladesh, China, and Indonesia had more than 
1 million small-for-gestational-age babies. 
Figure 2: Estimated prevalence of SGA births in 138 low-income and middle-income countries 
SGA=small for gestational age.
0–10
National prevalence of SGA (%)
10–20 20–30 30–40 40–50 Not estimated
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Discussion
Our data provide national and regional estimates for the 
prevalence and number of babies born small for 
gestational age and the co-occurrence of small for 
gestational age with preterm birth. 43·3 million infants 
(36% of livebirths) in countries of low or middle income 
were born either too small (small for gestational age) or 
too soon (preterm), or both, in 2010. The estimated 
burden of babies born small for gestational age is very 
high; 32·4 million neonates (27% of livebirths) are 
aﬀ ected, of whom 29·7 million infants were born at full 
term (≥37 weeks) and 10·6 million were born at term and 
with low birthweight (<2500 g). Almost 3 million infants 
(2%) were born preterm and small for gestational age.
The highest rates and numbers of babies born small for 
gestational age were in south Asia, where more than half 
Births in 2010 Prevalence (uncertainty range) Number of births (uncertainty range)*
Preterm birth2 SGA Term-SGA Preterm-SGA Preterm SGA Term-SGA Term-SGA 
and LBW
Preterm-
SGA
Caucasus and 
central Asia
1 643 000 9·2% (6·1–13·0) 15·0% 
(10·6–21·4)
12·9% 
(8·5–19·2)
2·1% (1·3–2·9) 151 300 240 700
(169 800–342 400)
207 000 82 800 33 700
East Asia 17 490 000 7·2% (5·4–9·0) 7·0% 
(4·2–11·6)
5·3% 
(2·7–10·1)
1·7% (1·1–2·1) 1 262 200 1 182 300
(720 700–1 975 000)
901 000 360 400 281 400
Southeast Asia 10 983 400 13·6% (9·3–18·6) 24·3% 
(19·5–30·2)
21·2% 
(16·7–27·1)
3·0% (2·0–4·3) 1 497 500 2 670 200
(2 143 400–3 318 900)
2 336 400 934 600 333 900
South Asia 38 753 000 13·3% (10·1–16·8) 44·5% 
(40·0–49·7)
41·5% 
(37·4–46·9)
2·9% (2·1–3·8) 5 159 300 17 350 300
(15 600 000–19 400 000)
16 200 000 6 475 100 1 150 300
West Asia 4 855 300 10·1% (6·9–14·3) 21·8% 
(17·6–27·2)
19·6% 
(15·4–25·3)
2·2% (1·5–3·2) 488 200 1 066 900
(863 100–1 334 300)
958 100 383 200 108 900
Oceania 263 100 7·4% (4·5–15·6) 21% 
(16·2–27·4)
19·4% 
(14·6–25·3)
1·6% (1·0–3·5) 19 500 55 300
(42 700–72 000)
51 000 20 400 4300
North Africa 3 543 000 7·3% (4·8–10·9) 9·6% 
(6·8–13·2)
8·5% 
(5·7–11·9)
1·2% (0·7–1·9) 259 200 337 600
(239 400–461 400)
296 000 77 000 41 600
Sub-Saharan 
Africa
32 085 500 12·3% (9·5–15·8) 25·5% 
(21·7–28·8)
23·5% 
(19·9–26·7)
2·0% (1·4–2·8) 3 936 800 8 157 300
(6 943 600–9 215 500)
7 525 200 1 956 500 632 200
Latin America and 
the Caribbean
10 844 500 8·6% (7·0–12·0) 12·5% 
(9·4–16·3)
10·7% 
(7·7–14·4)
1·8% (1·4–2·5) 929 300 1 374 000
(1 029 700–1 788 900)
1 180 100 342 200 193 900
Total† 120 461 300 11·3% (8·6–14·7) 27·0% 
(24·1–30·5)
24·7% 
(21·7–28·1)
2·3% (1·7–2·9) 13 702 800 32 434 800
(29 001 600–36 742 300)
29 654 600 10 632 200 2 780 100
SGA=small for gestational age. LBW=low birthweight. *Uncertainty ranges for all estimates are included in the appendix (pp 19–23). †Total for 138 countries of low and middle income. 
Table 2: Estimated prevalence and numbers of preterm and SGA infants, by UN-MDG region in 2010
Figure 3: Prevalence of SGA, preterm births, and LBW by UN-MDG region in 2010
AGA=appropriate for gestational age. SGA=small for gestational age. LBW=low birthweight.
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of babies small for gestational age are born and nearly one 
in two infants are born too small. The prevalence of babies 
born small for gestational age reached almost 50% in 
Pakistan and India, predicted largely on national rates for 
low birthweight, which were very high. The cutoﬀ  for 
small for gestational age at the 10th centile of the reference 
population was recommended by a WHO expert 
committee;5 however, a lower cutoﬀ  could be considered 
at the 3rd centile, which would indicate especially severe 
cases of small for gestational age, particularly in high-
burden settings. With a 3rd centile38 cutoﬀ , the prevalence 
of severe small-for-gestational-age births was 23% in 
south Asia, aﬀ ecting 3·9 million infants (analysis not 
shown). The lowest rates of babies born small for 
gestational age were noted in east Asia, largely aﬀ ected by 
data for China, where the reported low-birthweight rate 
was 2·4% (WHO Regional Oﬃ  ces, 2008).
A major challenge in estimating the global burden of 
babies born small for gestational age is selection of a 
common reference population. The Williams39 reference 
of Californian livebirths from 1970–76 (n=2 288 806) was 
recommended in 1995 by WHO6 in view of the multiracial 
population, representation at lower gestational ages, and 
association with survival. We chose the 1991 US birth 
reference population,8 which was published after the 
original WHO recommendation, because it is more 
recent than the Williams reference, has a large sample 
size (n=3 134 879) that better represents low gestational 
ages, covers a national and diverse multiethnic 
population, has well characterised methods to smooth 
centile curves and exclude outlying values, and is the 
most frequently cited reference in scientiﬁ c literature. 
Choosing a common reference for burden estimates is 
important, since the estimated prevalence of babies born 
small for gestational age varies substantially depending 
on the reference population chosen. For example, within 
a south Indian cohort, the estimated prevalence of babies 
born small for gestational age ranged from 10·5%40 to 
72·5%41 using the 10th centile cutoﬀ  of diﬀ erent reference 
populations, with the Alexander reference providing a 
prevalence of 56%8 (Joanne Katz, Johns Hopkins 
Bloomberg School of Public Health; personal 
communication). Another consideration is use of a 
birthweight-for-gestation curve versus an ultrasound-
based fetal-weight curve. For preterm infants, a 
birthweight-for-gestation reference might underestimate 
the true prevalence of intrauterine growth restriction 
because preterm infants could be small at birth because 
of pathological eﬀ ects, which led to the preterm birth, 
compared with babies who remain in utero.42 However, 
ultrasound-based fetal-weight estimation methods also 
have limitations. A standard proposed by WHO43 shifts 
the Hadlock distribution of fetal weights for every 
gestational age by a particular country’s mean birthweight 
at 40 weeks, thus setting by default any population-based 
small-for-gestational-age prevalence close to 10%. This 
strategy only identiﬁ es the most growth-restricted infants 
in that particular population, rather than establishing the 
burden of suboptimum growth. Most limitations of 
available fetal growth references are being addressed in 
the WHO Intergrowth study, which is currently taking 
place in eight geographically diverse settings and aims to 
develop international growth standards to describe 
optimum fetal growth and newborn nutritional status 
(completion in 2014).44 
Our analyses show important regional diﬀ erences in 
babies born small for gestational age and the composition 
of low birthweight. In south Asia, rates of low birthweight 
are high and many (65%) low-birthweight births are 
attributable to term-SGA infants. However, in 
sub-Saharan Africa and Latin America and the Caribbean, 
just over 50% of low-birthweight babies are preterm. 
Furthermore, low birthweight might not fully capture the 
increased risk of babies born too soon or too small. The 
median birthweight of an infant born at 33 weeks of 
gestation is around 2500 g for the Alexander distribution;8 
thus, many late preterm infants could weigh 2500 g or 
heavier. Two-thirds of term-SGA infants weigh 2500 g or 
more, although these babies are at lower risk of morbidity 
and mortality than their low-birthweight counterparts, 
particularly from non-communicable diseases in 
adulthood. 
Estimates of intrauterine growth restriction were 
reported by de Onis and colleagues in 1998.4 These 
researchers estimated that 13·7 million infants (11% of 
births) in low-income and middle-income countries were 
born at term and with a low birthweight, an indicator that 
was a proxy for intrauterine growth restriction. 
By comparison, we estimated that a total of 10·6 million 
Figure 4: Public health implications of the burden of preterm and SGA births for 120 million births in 
countries of low and middle income
AGA=appropriate for gestational age. SGA=small for gestational age. LBW=low birthweight. Adapted from 
reference 37, with permission of WHO.
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babies were born at term with low birthweight in countries 
of low and middle income in 2010. However, our 
estimation of small for gestational age also included two 
groups missing in the term and low-birthweight indicator: 
preterm-SGA infants who are at substantially higher risk 
of adverse outcomes;10 and babies born small for 
gestational age but weighing 2500 g or more. The 
estimates made by de Onis and colleagues were based on 
1996 rates of low birthweight from WHO and on older 
data from 1960–96, which used inputs from 60 datasets in 
low-income and middle-income countries at a time when 
less attention was paid to metrics for gestational age. 
Recent ﬁ ndings show temporal changes in the distribution 
of small-for-gestational-age and preterm births in low-
birthweight babies.45
Estimates of preterm, low-birthweight, and small-for-
gestational-age rates are imperfect because of gaps and 
biases in data. The methods used to ascertain gestational 
age varied between studies and might aﬀ ect estimation of 
gestational length. We included studies meeting a priori 
data-quality criteria for gestational age, and nine studies 
included ultrasound measures of gestational age. In 
several studies, last menstrual period was recorded 
prospectively during monthly pregnancy surveillance and, 
thus, this information was subject to less recall bias. We 
included information from both facility-based and 
community-based or population-based studies, and we 
attempted to assess biases. National data were available 
from Chile only.21 The WHO Global Survey was a facility-
based survey, which could be biased depending on the 
nature of the facility, the number of facilities in an area, 
and the proportion of deliveries that took place in the 
home. We included a covariate to control for facility bias. 
In community-based studies, neonatal weight is measured 
after birth and, therefore, a high proportion of birthweight 
data can be missing for early neonatal deaths. We excluded 
datasets that had a substantial amount of missing 
birthweight data (>25%), and we did sensitivity analyses 
with imputation of missing birthweight data.10 The 
prevalence of term-SGA and preterm-SGA did not change 
substantially. However, data for birthweight might have 
been missing more frequently among preterm-SGA 
babies, because these infants are at a higher risk of 
mortality and they might have died before weighing. 
Thus, our projections could underestimate the prevalence 
of preterm-SGA. Furthermore, in view of the use of 
birthweight rather than an ultrasound growth reference, 
the prevalence of preterm-SGA could be underestimated, 
because growth restriction has a relatively higher 
frequency in babies who are born preterm versus those 
who remain in utero for the full gestation period. Data for 
maternal HIV status were limited; HIV infection can be a 
risk factor for babies born small for gestational age, 
although risk is not so clearly deﬁ ned for preterm birth.46 
Finally, most of our datasets did not include data on 
stillbirths, which are more likely to be associated with fetal 
growth restriction and preterm birth, and our estimates 
do not capture this burden.
The dearth and quality of data on both birthweight and 
gestational age in countries of low and middle income 
have been key barriers to quantiﬁ cation of the burden of 
small-for-gestational-age babies or intrauterine growth 
restriction (panel). More than half of infants in low-
income and middle-income countries are never weighed 
at birth, particularly those born outside of facilities,1 and 
facility-based data are subject to selection biases. Inclusion 
of birthweight in household surveys (eg, demographic 
and health survey, multiple indicator cluster survey) since 
the 1990s has improved data availability, and methods to 
adjust data quality have been developed.1 Serial fetal 
ultrasonography is the gold standard for diagnosis of 
intrauterine growth restriction in high-resource settings, 
but small for gestational age at birth is the most commonly 
used indicator in countries of low and middle income. 
Data for gestational age are also troublesome. In low-
income and middle-income countries, ultrasound is 
Livebirths in 
201016
NMR 
201015
LBW 
births
Preterm 
births2
Term-SGA 
births
Preterm-SGA 
births
Number of SGA births 
(uncertainty range)
SGA 
prevalence
1 India 27 000 000 33·1 7 507 200 3 519 100 12 000 000 784 600 12 800 000 (11 500 000–14 300 000) 46·9%
2 Pakistan 4 700 000 36·1 1 232 800 748 100 2 061 300 166 800 2 228 100 (2 012 200–2 529 800) 47·0%
3 Nigeria 6 300 000 40·2 740 900 773 600 1 379 500 124 200 1 503 800 (1 275 300–1 709 100) 23·7%
4 Bangladesh 3 000 000 27·5 656 100 424 100 1 108 500 94 600 1 203 000 (1 071 800–1 369 200) 39·6%
5 China 17 000 000 9·4 398 400 1 172 300 810 700 261 400 1 072 100 (648 300–1 817 600) 6·5%
6 Indonesia 4 400 000 15·9 485 300 675 700 891 600 150 700 1 042 300 (814 800–1 309 300) 23·8%
7 Ethiopia 2 600 000 32·4 530 400 263 400 795 700 42 300 838 000 (698 900–957 600) 32·1%
8 Philippines 2 300 000 12·6 459 500 348 900 708 900 77 800 786 700 (641 600–937 900) 33·6%
9 Democratic 
Republic of 
Congo
2 900 000 47·4 275 800 341 400 574 600 54 800 629 500 (523 000–754 900) 21·9%
10 Sudan 1 400 000 31·5 438 600 188 300 565 000 30 200 595 200 (485 900–696 600) 41·7%
NMR=neonatal mortality rate. LBW=low birthweight. SGA=small for gestational age.
Table 3: Top ten countries with the highest numbers of SGA infants born in 2010
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generally not available and last menstrual period is used 
to date most pregnancies, which can be aﬀ ected by poor 
maternal recall, lactational amenorrhoea, variation in 
length of menstrual cycle, or injectable contraception. Last 
menstrual period has an estimated error of SD 3 weeks, 
clinical assessment SD 2 weeks, and ultrasound done 
before 20 weeks of gestation has an error of SD 7 days. 
Under-registration of very preterm births attributable to 
early death is also a problem.2 
Our ﬁ ndings have important programmatic and 
research implications for newborn health and survival, 
particularly because 43% of under-5 deaths happen 
during the neonatal period. Evidence for the primary 
prevention of preterm birth and fetal growth restriction is 
limited. In an analysis modelling high coverage of ﬁ ve 
evidence-based interventions in countries with a high 
development index, little reduction was seen in preterm 
birth rates.47 However, the ﬁ ndings underline the 
importance of further research in settings of low-income 
and middle-income countries about birth spacing and 
treatment of maternal infections. Nutritional 
supplementation programmes (balanced protein–energy 
supplementation) for women during pregnancy can 
reduce the risk of small-for-gestational-age births by a 
third,48 although evidence of eﬀ ectiveness at scale is 
scarce. Multiple micronutrient supplementation reduces 
the risk of babies born small for gestational age by 17%;49 
however, the eﬀ ect of supplementation varies across 
populations, with diﬀ ering baseline rates of malnutrition 
and access to obstetric care.
By contrast, interventions that improve the care and 
survival of preterm and small-for-gestational-age infants 
have major potential for immediate eﬀ ects and should be 
prioritised—eg, early feeding support (initiation of 
breastfeeding, alternative oral feeding methods), 
kangaroo mother care,50 early detection and treatment of 
neonatal infections,51 and neonatal resuscitation.52 These 
common interventions improve the management of 
small babies—whether due to preterm birth or 
intrauterine growth restriction—and have been proven 
to have great eﬀ ect, or are even judged standard care, in 
high-income settings. Yet, these simple low-cost 
interventions do not reach those small babies in the 
settings of greatest need.
Moving beyond birthweight metrics alone and 
delineating preterm birth and intrauterine growth 
restriction are important for advancing a healthy start in 
life. In 2010 in countries of low and middle income, 
Systematic review
No systematic national estimates have been published of the 
burden of babies born small for gestational age and its 
co-occurrence with preterm birth. To identify birth cohorts with 
birthweight and gestational age data required for secondary 
analysis, we did a systematic literature review of Medline and 
WHO regional databases with the terms: “preterm birth”, 
“intrauterine/fetal growth restriction”, OR “small for gestational 
age”, AND “developing countries”. We identiﬁ ed 45 birth cohorts 
from low-income and middle-income countries with adequate 
data and investigators willing to join the CHERG SGA-Preterm 
Birth Working Group. After ﬁ tting the statistical model with 
these data, we observed a high correlation between low 
birthweight and prevalence of small-for-gestational-age births. 
To include more data in the model, we did an additional 
literature review to identify studies that reported low 
birthweight and prevalence of small-for-gestational-age births 
using the 1991 US national birthweight reference (Alexander, 
1991).8 We searched Medline and Scopus to identify studies 
reporting either the prevalence of small-for-gestational-age and 
low-birthweight births or the prevalence of small-for-
gestational-age babies using the Alexander reference, using 
prespeciﬁ ed inclusion criteria. Search terms included [“fetal 
growth restriction”, “intrauterine growth restriction”, OR “small 
for gestational age”] AND “low birthweight”, using MESH subject 
heading terms. Six reports were identiﬁ ed that reported 
prevalence of small for gestational age and low birthweight; 
however, none reported the prevalence of babies born at term 
and small for gestational age (term-SGA) or preterm and small 
for gestational age (preterm-SGA) and were therefore excluded. 
Secondary analyses and statistical modelling were done to 
estimate the prevalence of term-SGA for 138 countries of low 
and middle income for the year 2010. We also estimated the 
proportion of preterm-SGA using meta-analyses.
Interpretation
In the year 2010, 32·4 million (27%) small-for-gestational-age 
livebirths were estimated, of which 2·8 million babies (2% of 
births) were preterm-SGA. The prevalence of term-SGA ranged 
from 5·3% in east Asia to 41·5% in south Asia, and preterm-SGA 
ranged from 1·2% in north Africa to 3·0% in southeast Asia. Of the 
18 million low-birthweight babies born every year, about 59% are 
because of growth restriction in term infants and 41% are 
attributable to prematurity. Previously, babies born at term and 
low birthweight were a proxy for intrauterine growth restriction; 
last estimates date from 1998, when about 13·7 million infants 
(11% of births) in countries of low and middle income were born 
at term and low birthweight, compared with our estimate of 
10·6 million babies (9% of births) for the year 2010. However, the 
number of babies born at term and low birthweight does not fully 
capture the burden of growth restriction and misses infants born 
small for gestational age above the 2500 g cutoﬀ  in addition to 
those who are both preterm and small for gestational age. These 
babies might have increased risk of morbidity or mortality. 
Globally, a huge burden of fetal growth restriction exists, 
particularly concentrated in south Asia. Implementation of simple 
and cost-eﬀ ective interventions that increase survival and reduce 
morbidity of these babies born too small is an urgent priority.  
Panel: Research in context
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32·4 million neonates, or one in every four babies, were 
classiﬁ ed as small for gestational age, closely linked to 
13·7 million babies born too soon. Half of infants born 
small for gestational age were in south Asia, where one 
of two babies was born too small. To improve the 
epidemiology and adequately monitor the eﬀ ect of 
interventions, systems are needed urgently to better 
capture and track pregnancy outcomes and to increase 
the quantity and quality of both birthweight and 
gestational age data. Eﬀ ective low-technology inter-
ventions are available now to deliver care to these most 
vulnerable babies born too small or too soon. 
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